Retinopathy Associated with Adjuvant Interferon in a Patient with Malignant Melanoma: A Case Report and Review of the Literature

Dogan, Mahmut (2019) Retinopathy Associated with Adjuvant Interferon in a Patient with Malignant Melanoma: A Case Report and Review of the Literature. Ophthalmology Research: An International Journal, 11 (2). pp. 1-7. ISSN 2321-7227

[thumbnail of Dogan1122019OR52921.pdf] Text
Dogan1122019OR52921.pdf - Published Version

Download (324kB)

Abstract

Interferons are kinds of proteins with immuneregulatory, antiviral and anti-proliferative functions. Interferons are widely used worldwide for the treatment of many diseases including cancer, hepatit C and immune mediated disease such as multiple sclerosis. Long-term use of interferons have some side effects. However, interferons have ophthalmologic side effects. Ocular toxicity may occur at any time during treatment. There is no association between the dose or duration of interferon treatment and ocular toxicity. Although visual acuity returns to normal in most patients when interferon is discontinued, vision loss may be permanent.

Item Type: Article
Subjects: STM Digital Press > Medical Science
Depositing User: Unnamed user with email support@stmdigipress.com
Date Deposited: 27 Apr 2023 08:09
Last Modified: 21 May 2024 13:31
URI: http://publications.articalerewriter.com/id/eprint/417

Actions (login required)

View Item
View Item